Biotech · Private company
Adneuris Therapeutics, Inc.
Track this companyFree. Adds Adneuris Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials22 recruiting or active
Pipeline programs2From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline2
- Cebranopadol 400 ugPhase 3 · PainClinicalTrials.gov · fetched Nov 12, 2026
- CebranopadolPhase 2 · Chronic PainClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials2
- A Study of Cebranopadol for Opioid Withdrawal Symptoms in Adults With Chronic PainPHASE2 · RECRUITING · started Oct 1, 2026ClinicalTrials.gov NCT07874620 · fetched Nov 12, 2026
- An Open-Label, Safety and Efficacy Study of Cebranopadol in Participants With Acute Pain With Surgical or Non-Surgical OriginPHASE3 · RECRUITING · started Sep 22, 2026ClinicalTrials.gov NCT07845071 · fetched Nov 12, 2026